As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Merck & Co., Inc.: Marex Group plc, Hudson Bay Capital Management LP, Wolverine Trading LLC, Nomura Holdings Inc., Man Group plc, Hudson Bay Capital Management LP, Group One Trading LLC, BNP Paribas Financial Markets, Bank of America Corp DE, Jane Street Group LLC, Raymond James Financial Inc., Caption Management LLC, Volterra Technologies LP, Squarepoint Ops LLC, Alphadyne Asset Management LP, Qube Research & Technologies Ltd, Maven Securities LTD, Capula Management Ltd, Marshall Wace LLP, Walleye Capital LLC, Walleye Trading LLC, Lido Advisors LLC, Delta Accumulation LLC, Capital Fund Management S.A., Jefferies Financial Group Inc., Eisler Capital Management Ltd., MAI Capital Management, JPMorgan Chase & Co., Citigroup Inc., Garda Capital Partners LP, Mirae Asset Securities USA Inc., Simplex Trading LLC, Bank of Montreal Can, Wolverine Asset Management LLC, Insight Advisors LLC PA, Allianz Asset Management GmbH, Twin Tree Management LP, Concurrent Investment Advisors LLC, Total Wealth Planning & Management Inc., and IMC Chicago LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.